HomeSBS • FRA
add
Stratec SE
Previous close
€41.70
Day range
€42.50 - €43.30
Year range
€36.55 - €68.50
Market cap
542.21M EUR
Avg Volume
24.00
P/E ratio
43.34
Dividend yield
1.27%
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 74.23M | 10.84% |
Operating expense | 8.43M | 0.26% |
Net income | 5.54M | 23.02% |
Net profit margin | 7.46 | 10.85% |
Earnings per share | 0.57 | — |
EBITDA | 15.32M | 44.52% |
Effective tax rate | 28.48% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 33.53M | 47.93% |
Total assets | 466.58M | 17.38% |
Total liabilities | 233.25M | 35.36% |
Total equity | 233.33M | — |
Shares outstanding | 12.16M | — |
Price to book | 2.17 | — |
Return on assets | 6.83% | — |
Return on capital | 8.92% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 5.54M | 23.02% |
Cash from operations | 8.72M | 172.60% |
Cash from investing | 1.51M | 172.78% |
Cash from financing | 8.81M | 210.91% |
Net change in cash | 19.22M | 263.80% |
Free cash flow | -50.85M | -186.56% |
About
STRATEC SE is a company with worldwide operations that develops and produces analyzer systems and automation systems in the field of in-vitro-diagnostics. As a classic OEM supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also develops system software and software to connect the systems to laboratory software. STRATEC is also responsible for development documentation, testing and delivering the systems, and supplying spare parts and consumables. STRATEC's customers are well known diagnostic companies like SIEMENS, Bio-Rad or Hologic. Wikipedia
Founded
1979
Website
Employees
1,473
